Lens Technology Balans Gezondheid

Financiële gezondheid criteriumcontroles 6/6

Lens Technology heeft een totaal eigen vermogen van CN¥47.5B en een totale schuld van CN¥15.8B, wat de schuld-eigenvermogensverhouding op 33.2% brengt. De totale activa en totale passiva bedragen respectievelijk CN¥80.9B en CN¥33.5B. De EBIT Lens Technology is CN¥3.8B waardoor de rentedekking -42.1 is. Het heeft contanten en kortetermijnbeleggingen van CN¥9.8B.

Belangrijke informatie

33.2%

Verhouding schuld/eigen vermogen

CN¥15.77b

Schuld

Rente dekkingsratio	-42.1x
Contant	CN¥9.84b
Aandelen	CN¥47.48b
Totaal verplichtingen	CN¥33.46b
Totaal activa	CN¥80.95b

Recente financiële gezondheidsupdates

Lens Technology (SZSE:300433) Has A Pretty Healthy Balance Sheet

Mar 15

Recent updates

Lens Technology Co., Ltd. (SZSE:300433) Looks Just Right With A 54% Price Jump

Oct 08

Lens Technology Co., Ltd. (SZSE:300433) Shares Could Be 24% Above Their Intrinsic Value Estimate

Aug 14

We Think That There Are Some Issues For Lens Technology (SZSE:300433) Beyond Its Promising Earnings

Apr 30

Is Now An Opportune Moment To Examine Lens Technology Co., Ltd. (SZSE:300433)?

Apr 02

Lens Technology (SZSE:300433) Has A Pretty Healthy Balance Sheet

Mar 15

Calculating The Intrinsic Value Of Lens Technology Co., Ltd. (SZSE:300433)

Feb 29

Analyse van de financiële positie

Kortlopende schulden: De korte termijn activa ( CN¥30.6B ) 300433 } overtreffen de korte termijn passiva ( CN¥24.0B ).

Langlopende schulden: De kortetermijnactiva 300433 ( CN¥30.6B ) overtreffen de langetermijnschulden ( CN¥9.5B ).

Schuld/ eigen vermogen geschiedenis en analyse

Schuldniveau: De netto schuld/eigen vermogen ratio ( 12.5% ) 300433 wordt als voldoende beschouwd.

Schuld verminderen: De schuld/eigen vermogen-ratio van 300433 is de afgelopen 5 jaar gedaald van 103.1% naar 33.2%.

Schuldendekking: De schuld van 300433 wordt goed gedekt door de operationele kasstroom ( 72.3% ).

Rentedekking: 300433 verdient meer rente dan het betaalt, dus de dekking van rentebetalingen is geen probleem.

Lens Technology Balans Gezondheid

Financiële gezondheid criteriumcontroles 6/6

Belangrijke informatie

Recente financiële gezondheidsupdates

Lens Technology (SZSE:300433) Has A Pretty Healthy Balance Sheet

Recent updates

Third quarter 2024 earnings: EPS and revenues exceed analyst expectations

Now 20% overvalued after recent price rise

Lens Technology Co., Ltd. (SZSE:300433) Looks Just Right With A 54% Price Jump

New minor risk - Share price stability

Lens Technology Co., Ltd. to Report Q3, 2024 Results on Oct 21, 2024

Investor sentiment improves as stock rises 16%

Second quarter 2024 earnings: EPS and revenues miss analyst expectations

Lens Technology Co., Ltd. (SZSE:300433) Shares Could Be 24% Above Their Intrinsic Value Estimate

Now 22% overvalued after recent price rise

When Should You Buy Lens Technology Co., Ltd. (SZSE:300433)?

Price target increased by 7.1% to CN¥17.66

Lens Technology (SZSE:300433) Has Some Way To Go To Become A Multi-Bagger

Lens Technology Co., Ltd. to Report First Half, 2024 Results on Aug 26, 2024

There's Reason For Concern Over Lens Technology Co., Ltd.'s (SZSE:300433) Price

We Think That There Are Some Issues For Lens Technology (SZSE:300433) Beyond Its Promising Earnings

New minor risk - Earnings quality

Full year 2023 earnings: Revenues exceed analysts expectations while EPS lags behind

Is Now An Opportune Moment To Examine Lens Technology Co., Ltd. (SZSE:300433)?

Lens Technology Co., Ltd. to Report Q1, 2024 Results on Apr 24, 2024

Lens Technology (SZSE:300433) Has A Pretty Healthy Balance Sheet

Now 23% overvalued after recent price rise

Calculating The Intrinsic Value Of Lens Technology Co., Ltd. (SZSE:300433)

Lens Technology Co., Ltd. to Report Fiscal Year 2023 Results on Apr 22, 2024

Third quarter 2023 earnings: EPS and revenues exceed analyst expectations

Second quarter 2023 earnings: EPS and revenues miss analyst expectations

Lens Technology Co., Ltd. Announces 2022 Final Profit Distribution Plan to Be Implemented (A Shares), Payment Date of 01 June 2023

Lens Technology Approves Cash Dividend for 2022

Full year 2022 earnings: EPS and revenues miss analyst expectations

Consensus EPS estimates increase by 28%

Full year 2022 earnings released: EPS: CN¥0.50 (vs CN¥0.42 in FY 2021)

Now 20% undervalued

High number of new directors

Third quarter 2022 earnings: EPS and revenues miss analyst expectations

Second quarter 2022 earnings: EPS and revenues miss analyst expectations

High number of new directors

Price target decreased to CN¥14.79

Lens Technology Co., Ltd. Announces Final Cash Dividend on A Shares for 2021, Payable on 01 June 2022

Consensus EPS estimates increase by 52%

Lens Technology Co., Ltd. Approves Cash Dividend for 2021

Price target decreased to CN¥19.38

Consensus revenue estimates fall by 17%

First quarter 2022 earnings: EPS and revenues miss analyst expectations

Lens Technology Co., Ltd. Proposes Cash Dividend for 2021

Price target decreased to CN¥22.29

Price target decreased to CN¥22.91

Full year 2021 earnings: EPS and revenues miss analyst expectations

Price target decreased to CN¥25.43

Investor sentiment improved over the past week

Price target decreased to CN¥30.68

Third quarter 2021 earnings released: EPS CN¥0.20 (vs CN¥0.35 in 3Q 2020)

Price target decreased to CN¥37.21

Price target decreased to CN¥37.21

Second quarter 2021 earnings released: EPS CN¥0.22 (vs CN¥0.24 in 2Q 2020)

Independent Director Shao Zhang has left the company

Independent Director Xiang Xi Tang has left the company

Director Xin Zhou has left the company

Price target increased to CN¥40.82

Lens Technology Co., Ltd. Approves Cash Dividend for the Year 2020

Lens Technology Co., Ltd. Proposes Final Cash Dividend for the Year 2020

Full year 2020 earnings released: EPS CN¥1.12 (vs CN¥0.62 in FY 2019)

New 90-day low: CN¥28.83

Analysts update estimates

Investor sentiment deteriorated over the past week

Investor sentiment improved over the past week

New 90-day high: CN¥37.00

New 90-day low: CN¥30.29

New 90-day low: CN¥30.38

Analysts update estimates

Third-quarter earnings released: Revenue and earnings beat expectations

Third quarter earnings released

Lens Technology Co., Ltd. to Report Q3, 2020 Results on Oct 27, 2020

Lens Technology Co., Ltd. (SZSE:300433) entered into an agreement to acquire Meeca Technology (Taizhou) Co. Ltd. and Topo Technology (Taizhou) Co., Ltd. from Lyra International Co., Ltd. for $1.4 billion (CNY 9.9 billion).

New 90-day high - CN¥36.77

Price target raised to CN¥36.29